Description

Essential coenzyme; human trials largely use the precursor NMN

NAD+ is a critical coenzyme involved in cellular activities including ATP generation, DNA repair, and enzyme regulation. Produced under strict quality conditions to ensure exceptional purity and consistency. Central focus in studies related to aging, mitochondrial performance, and cell renewal. Allows investigators to explore its influence on oxidative stress, inflammatory responses, and sirtuin pathway activity.

References

  1. Yi L, et al. The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29-43. PMID: 36482258 | DOI: 10.1007/s11357-022-00705-1
  2. Song Q, et al. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023;14(6):1416-1435. PMID: 37619764 | DOI: 10.1016/j.advnut.2023.08.008

Note: Human clinical data center on the NAD+ precursor NMN, which raises circulating NAD+ levels.

Certificate of Analysis

Original laboratory report for NAD+. Product and labeled strength matched. Vial lot/current-stock association has not been confirmed. Refer to the original report for laboratory findings.

Verify this batch

Print or download (PDF)

Serial: COA-1001274-DD5V · Integrity verified